WHO/FDA registered Antimalarial, Pyramax approved for coronavirus clinical trials
Pyramax is also being tried in South Africa, Kenya and Burkina Faso to pick African efficacy data The World Health Organisation prequalified and Ghana Food and Drugs Authority registered Antimalarial Pyramax (Artesunate-Pyronaridine), a fixed-dose combination medication for the treatment of malaria, has been approved for clinical trials for Covid-19 in South Korea. Also, it is being tried in South Africa, Kenya and Burkina Faso to pick African efficacy data. The study, which is being led by the Liverpool School of Hygiene and Tropical Medicine, has the primary purpose to compare and evaluate ...
Source: ghanavisions.com
